Yuanquan Yang
Clinical trials sponsored by Yuanquan Yang, explained in plain language.
-
Can a simple infusion stop Immunotherapy's worst side effects?
Disease control Recruiting nowThis study tests whether giving siltuximab alongside restarting immunotherapy can prevent severe immune-related side effects in people with advanced cancer. About 40 adults who previously had serious side effects from immunotherapy will receive siltuximab to calm the immune syste…
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for bladder cancer patients who can't have standard chemo
Disease control Recruiting nowThis study tests two drugs, futibatinib and durvalumab, given before surgery to remove the bladder in people with muscle-invasive bladder cancer who cannot take standard chemotherapy. The goal is to see if this combination can eliminate or shrink the cancer enough to improve outc…
Phase: PHASE2 • Sponsor: Yuanquan Yang • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC